Internal Medicine, Pulmonary Disease · Mayaguez, PR
NPI
1154313849
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
55 North Basora Street, Suite 210
Mayaguez, PR, 00680
Phone (787) 833-5090
Medicare paid, 2024
$2,315
52 services
Medicare patients, 2024
13
Average age 74
Drug cost, 2024
$3.7M
10,236 prescriptions
Company payments, 2025
$1,103
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rosa I Roman Carlo was code 99213 (office e&m - established), 29 times for 12 patients. In total Rosa I Roman Carlo billed 52 services in 6 codes, and Medicare paid $2,315.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 29 | 12 | $47.52 | $1,378 |
By year: 2022 $4,648 for 93 services; 2023 $4,045 for 86 services; 2024 $2,315 for 52 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rosa I Roman Carlo prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 1,561 prescriptions and refills. In total Rosa I Roman Carlo wrote 10,236 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,561 | 1,585 | 311 | $63K |
| Fluticasone Propionate Generic | 810 | 977 | 192 | $11K |
| Spiriva Respimat Tiotropium Bromide | 805 | 808 | 145 | $430K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 754 | 791 | 152 | $202K |
| Levocetirizine Dihydrochloride Generic | 729 | 733 | 137 | $6,897 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 613 | 619 | 118 | $301K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 415 | 421 | 86 | $274K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 362 | 362 | 67 | $59K |
| Levalbuterol Tartrate Hfa Levalbuterol Tartrate | 330 | 330 | 63 | $20K |
| Montelukast Sodium Generic | 321 | 449 | 78 | $3,106 |
| Zafirlukast Generic | 284 | 376 | 56 | $27K |
| Famotidine Generic | 274 | 288 | 65 | $1,764 |
| Prednisone Generic | 235 | 236 | 79 | $1,027 |
| Fluticasone Propionate Hfa Fluticasone Propionate | 234 | 234 | 63 | $45K |
| Mycophenolate Mofetil Generic | 201 | 201 | 31 | $8,969 |
Brand drugs: 5,182 claims; generic drugs: 5,054 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rosa I Roman Carlo $1,103 ($1,103 in general payments such as food, travel and fees) from 5 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $741.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.